Hikma Pharmaceuticals Aktie
25,40
EUR
+0,80
EUR
+3,25
%
21,48
GBP
+0,36
GBP
+1,70
%
Werbung
Hikma Pharmaceuticals Aktie Analyse
14.12.12 | Hikma Pharmaceuticals overweight | Morgan Stanley | |
15.10.12 | Hikma Pharmaceuticals overweight | J.P. Morgan Cazenove | |
10.10.11 | Hikma Pharmaceuticals buy | Citigroup Corp. | |
21.07.09 | Hikma Pharmaceuticals | Global Biotech Investing |
Werbung
Werbung